Because of the variations in trial design and reporting, it was not possible to combine the results from all four trials for anaemia (Hb < 100 or 110 g/l) and severe anaemia (Hb < 70 or 80 g/l) [28]. The gene discussed is GSTM1; the disease is anemia.